Your browser doesn't support javascript.
loading
Radiation-Induced Cardiovascular Toxicities.
Badiyan, Shahed N; Puckett, Lindsay L; Vlacich, Gregory; Schiffer, Walter; Pedersen, Lauren N; Mitchell, Joshua D; Bergom, Carmen.
Afiliação
  • Badiyan SN; Department of Radiation Oncology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Puckett LL; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Vlacich G; Department of Radiation Oncology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Schiffer W; Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA.
  • Pedersen LN; Department of Radiation Oncology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Mitchell JD; Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA.
  • Bergom C; Cardio-Oncology Center of Excellence, Washington University, St. Louis, MO, USA.
Curr Treat Options Oncol ; 23(10): 1388-1404, 2022 10.
Article em En | MEDLINE | ID: mdl-36087234
ABSTRACT
OPINION STATEMENT Several seminal papers over the last decade have furthered our recognition of radiation-induced heart disease (RIHD) as an important potential toxicity following radiation therapy (RT) to the chest. Investigators continue to evaluate the subacute and long-term effects of RT. In addition, studies are determining whether certain cardiac substructures are more sensitive to radiation, working to identify risk factors for the development of RIHD, and testing screening and mitigation strategies for RIHD. Multiple groups and expert consensus guidelines have published whole-heart and cardiac substructure dose constraints based on available data and cancer type. The authors recommend readers to familiarize themselves with the guidelines for screening and mitigating RIHD in adults and children, which advocate for cardiovascular risk assessment and reduction before and following RT, as well as cardiovascular imaging at appropriate follow-up intervals for early recognition of subclinical cardiovascular disease. Referrals to cardiology or cardio-oncology can also be helpful in prevention, screening, and mitigation strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Doenças Cardiovasculares / Cardiopatias / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Curr Treat Options Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Doenças Cardiovasculares / Cardiopatias / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Curr Treat Options Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos